The Canada Border Services Agency (CBSA) continues its ongoing development and implementation of the CBSA Assessment and Revenue Management (CARM) program, and changes are coming that could affect ...

Short interest in CARISMA Therapeutics Inc (NASDAQ:CARM) decreased during the last reporting period, falling from 484.88K to 324.34K. This put 0.97% of the company's publicly available shares short.